FREE Account Opening + No Clearing Fees
Loading...
April 25, 2023 - April 27, 2023

Mankind Pharma IPO Latest News Today

Track all the latest updates and news of Mankind Pharma IPO.

  1. Mankind Pharma IPO: Here�s how to check allotment status online

    May 3, 2023 7:02:00 PM

    Mankind Pharma is likely to announce its share allotment status on May 3. The IPO received great demand from investors as the issue was subscribed 15.32 times. The shares will be listed on May 8 ...

    Published by : Business Insider India
  2. Mankind Pharma Block Deal � Shares worth ?770 crore change hands

    July 10, 2024 7:00:00 AM

    CNBC-TV18 had reported on Tuesday that Capital Group Affiliate, Hema CIPEF plans to sell 0.9% of the company's equity via block deals valued at nearly ?762.6 crore.

    Published by : cnbctv18
  3. Mamaearth, Mankind Pharma, ideaForge, and more: Indian IPOs that delivered gains and losses for investors in 2023

    November 9, 2023 1:05:00 PM

    The IPO received significant attention, with a subscription rate of 106.06 times. Mankind Pharma shares concluded their listing day with a substantial premium of 32% on NSE at Rs 1397.6. Currently ...

    Published by : Business Today
  4. April 25; check issue size, listing date, and more

    April 3, 2024 10:52:00 PM

    and upto 50,000 shares by Link Investment Trust Tek TBO IPO: Here's what a host of brokerage firms say about the issue Indegene IPO: All details you need know including price band, key dates ...

    Published by : Business Today
  5. Bain Capital-backed Emcure Pharma IPO to open on July 3: Namita Thapar to offload stake�Top 10 things to know

    July 1, 2024 4:59:00 AM

    Emcure Pharmaceuticals IPO price band has been set in the range ... of 33.86), Torrent Pharmaceutical Ltd (with a P/E of 57.74), Mankind Pharma (with a P/E of 45.30), Abbott India Ltd (with ...

    Published by : Mint
  6. Indias Emcure Pharma jumps 35% in debut trade at $223 mln valuation

    July 10, 2024 9:13:00 AM

    Indian drugmaker Emcure Pharmaceuticals' shares rose 34.9% in debut trade on Wednesday, beating analysts' estimates and valuing the company at 18.64 billion rupees ($223.3 million), as its strong ...

    Published by : Reuters
  7. Emcure Pharmaceuticals IPO Day 2: From key risks to financials, here are 10 things to know from RHP before subscribing

    July 4, 2024 2:44:00 PM

    Also Read: Emcure Pharmaceuticals IPO day 2: GMP, subscription status ... Torrent Pharmaceutical Ltd (P/E: 57.74), Mankind Pharma (P/E: 45.30), Abbott India Ltd (P/E: 47.43), J.

    Published by : MSN
  8. Bain-backed Emcure Pharma attracts bids worth $11 bn in IPO

    July 5, 2024 3:30:00 AM

    The Bain Capital-backed company's IPO was fully subscribed on the first day of bidding ... The generics market is dominated by firms such as Sun Pharma, Mankind Pharma, Torrent Pharma and Abbott India ...

    Published by : VCCircle
  9. Emcure Pharmaceuticals IPO: Shark Tanks Namita Thapar likely to earn ?127 crore from OFS

    July 3, 2024 4:12:00 AM

    Emcure Pharmaceuticals IPO, which is set to start with a share ... (RHP), are Torrent Pharmaceutical Ltd (P/E of 57.74), Mankind Pharma (P/E of 45.30), Abbott India Ltd (P/E of 47.43), J.

    Published by : MSN
  10. Emcure Pharmaceuticals IPO to open on July 3rd

    June 28, 2024 6:47:00 PM

    The IPO comprises a fresh issue of ?800 Crore ... Alkem Laboratories, Torrent Pharmaceuticals, Mankind Pharma, Abbott India, and JB Chemicals. The company will debut on the BSE and NSE on ...

    Published by : India Infoline
  11. Emcure Pharmaceuticals gets SEBI approval for IPO

    June 21, 2024 10:38:00 PM

    Use of IPO Proceeds Emcure Pharmaceuticals plans ... Alkem Labs, Torrent Pharma, Mankind Pharma, and Abbott India.

    Published by : India Infoline

Mankind Pharma IPO Alerts

1. Mankind Pharma IPO Listing Date & Info  Monday, May 8, 2023 12:27:54 PM

The IPO Shares of Mankind Pharma Limited IPO are proposed to list on Tuesday, May 9, 2023 at BSE, NSE. The public issue of Mankind Pharma IPO was opened on Apr 25, 2023 and closed for subscription on Apr 27, 2023. Mankind Pharma IPO Listing Date and Information:

Mankind Pharma Limited Listing Date

Listing DateTuesday, May 9, 2023
BSE Script Code543904
NSE SymbolMANKIND
Listing InB Group of Securities
ISININE634S01028
Issue Price[.]
Face Value₹1 Per Equity Share

2. Mankind Pharma IPO Allotment Status  Thursday, May 4, 2023 3:44:10 PM

The allotment status of Mankind Pharma Limited IPO is now available online. The public issue of Mankind Pharma IPO was open on Apr 25, 2023 and closed for subscription on Apr 27, 2023. The equity shares of the company to be list at BSE, NSE
.

3. Mankind Pharma IPO Opens  Wednesday, April 19, 2023 8:29:37 AM

Mankind Pharma Limited is entering in the capital market with an IPO of 40,058,844 Equity Shares of Rs 1 aggregating up to Rs 4,326.36 Crore. The price for the issue has been set at Rs 1026 - Rs 1080 Per Equity Share.

Incorporated in 1991, Mankind Pharma Limited develops, manufactures, and markets pharmaceutical formulations across various acute and chronic therapeutic areas and several consumer healthcare products.

The issue opens on Apr 25, 2023 and closes for subscription on Apr 27, 2023. The equity shares of the company to be list at BSE, NSE.

4. Mankind Pharma IPO Closes  Wednesday, April 19, 2023 8:29:37 AM

The issue of Mankind Pharma Limited opens on Apr 25, 2023 and closes for subscription on Apr 27, 2023. The equity shares of the company to be list at BSE, NSE. The price for the issue has been set at Rs 1026 - Rs 1080 Per Equity Share.

Mankind Pharma IPO News & Events FAQs

The Mankind Pharma IPO is proposed to open on April 25, 2023. The IPO application ends on April 27, 2023.

Retail investors can apply in the retail or non-institutional investor category from April 25, 2023 to April 27, 2023. The Mankind Pharma IPO can be applied online through Net Bank (ASBA method) or the stock broker (UPI method).

The Mankind Pharma IPO will open for subscription on April 25, 2023. The public issue will close on April 27, 2023.